137
Views
0
CrossRef citations to date
0
Altmetric
Review

An overview of the efficacy, safety, and predictors of achalasia treatments

ORCID Icon, &
Pages 1241-1254 | Received 12 Jun 2023, Accepted 17 Nov 2023, Published online: 21 Nov 2023

References

  • Pressman A, Behar J. Etiology and pathogenesis of idiopathic achalasia. J Clin Gastroenterol. 2017;51(3):195–202. doi: 10.1097/MCG.0000000000000780
  • Jeon HH, Kim JH, Youn YH, et al. Clinical characteristics of patients with untreated achalasia. J Neurogastroenterol Motil. 2017;23(3):378–384. doi: 10.5056/jnm16177
  • van Hoeij FB, Ponds FA, Smout AJ, et al. Incidence and costs of achalasia in the Netherlands. Neurogastroenterol Motil. 2018;30. doi: 10.1111/nmo.13195
  • Harvey PR, Thomas T, Chandan JS, et al. Incidence, morbidity and mortality of patients with achalasia in England: findings from a study of nationwide hospital and primary care data. Gut. 2019;68(5):790–795. doi: 10.1136/gutjnl-2018-316089
  • Sadowski DC, Ackah F, Jiang B, et al. Achalasia: incidence, prevalence and survival. A population-based study. Neurogastroenterol Motil. 2010;22(9):e256–261. doi: 10.1111/j.1365-2982.2010.01511.x
  • Samo S, Carlson DA, Gregory DL, et al. Incidence and prevalence of achalasia in central Chicago, 2004-2014, Since the widespread use of high-resolution manometry. Clin Gastroenterol Hepatol. 2017;15:366–373. doi: 10.1016/j.cgh.2016.08.030
  • Bredenoord AJ, Fox M, Kahrilas PJ, et al. Chicago classification criteria of esophageal motility disorders defined in high resolution esophageal pressure topography. Neurogastroenterol Motil. 2012;24(Suppl 1):57–65. doi: 10.1111/j.1365-2982.2011.01834.x
  • Patel DA, Lappas BM, Vaezi MF. An overview of achalasia and its subtypes. Gastroenterol Hepatol (N Y). 2017;13:411–421.
  • Bassotti G, Annese V. Review article: pharmacological options in achalasia. Aliment Pharmacol Ther. 1999;13:1391–1396. doi:10.1046/j.1365-2036.1999.00645.x
  • Nassri A, Ramzan Z. Pharmacotherapy for the management of achalasia: Current status, challenges and future directions. World J Gastrointest Pharmacol Ther. 2015;6:145–155. doi:10.4292/wjgpt.v6.i4.145
  • Pasricha PJ, Ravich WJ, Hendrix TR, et al. Treatment of achalasia with intrasphincteric injection of botulinum toxin. A pilot trial. Ann Intern Med. 1994;121:590–591. doi: 10.7326/0003-4819-121-8-199410150-00006
  • Pasricha PJ, Ravich WJ, Hendrix TR, et al. Intrasphincteric botulinum toxin for the treatment of achalasia. N Engl J Med. 1995;332(12):774–778. doi: 10.1056/NEJM199503233321203
  • Cariati M, Chiarello MM, Cannistra M, et al. Gastrointestinal Uses of Botulinum Toxin. Handb Exp Pharmacol. 2021;263:185–226.
  • Kadakia SC, Wong RK. Pneumatic balloon dilation for esophageal achalasia. Gastrointest Endosc Clin N Am. 2001;11:325–346, vii. doi:10.1016/S1052-5157(18)30074-6
  • Cheatham JG, Wong RK. Current approach to the treatment of achalasia. Curr Gastroenterol Rep. 2011;13:219–225. doi:10.1007/s11894-011-0190-z
  • Borhan-Manesh F, Kaviani MJ, Taghavi AR. The efficacy of balloon dilation in achalasia is the result of stretching of the lower esophageal sphincter, not muscular disruption. Dis Esophagus. 2016;29(3):262–266. doi: 10.1111/dote.12314
  • Tsuboi K, Omura N, Yano F, et al. Data analyses and perspectives on laparoscopic surgery for esophageal achalasia. World J Gastroenterol. 2015;21:10830–10839. doi: 10.3748/wjg.v21.i38.10830
  • Inoue H, Minami H, Kobayashi Y, et al. Peroral endoscopic myotomy (POEM) for esophageal achalasia. Endoscopy. 2010;42(4):265–271. doi: 10.1055/s-0029-1244080
  • Sharma P, Stavropoulos SN. Is peroral endoscopic myotomy the new gold standard for achalasia therapy? Dig Endosc. 2023;35:173–183. doi:10.1111/den.14477
  • SN S, RJ M, Friedel D, et al. The International per oral endoscopic myotomy Survey (IPOEMS): a snapshot of the global POEM experience. Surg Endosc. 2013;27:3322–3338.
  • Oude Nijhuis RAB, Zaninotto G, Roman S, et al. European guidelines on achalasia: United European Gastroenterology and European Society of Neurogastroenterology and motility recommendations. United Eur Gastroenterol J. 2020;8(1):13–33. doi: 10.1177/2050640620903213
  • Dressler D. Clinical applications of botulinum toxin. Curr Opin Microbiol. 2012;15(3):325–336. doi: 10.1016/j.mib.2012.05.012
  • Ramzan Z, Nassri AB. The role of botulinum toxin injection in the management of achalasia. Curr Opin Gastroenterol. 2013;29:468–473. doi:10.1097/MOG.0b013e328362292a
  • Annese V, Bassotti G, Coccia G, et al. Comparison of two different formulations of botulinum toxin a for the treatment of oesophageal achalasia. The gismad achalasia study group. Aliment Pharmacol Ther. 1999;13:1347–1350. doi: 10.1046/j.1365-2036.1999.00602.x
  • Richter JE. Modern management of achalasia. Curr Treat Options Gastroenterol. 2005;8(4):275–283. doi: 10.1007/s11938-005-0020-1
  • Cuilliere C, Ducrotte P, Zerbib F, et al. Achalasia: outcome of patients treated with intrasphincteric injection of botulinum toxin. Gut. 1997;41(1):87–92. doi: 10.1136/gut.41.1.87
  • D’Onofrio V, Annese V, Miletto P, et al. Long-term follow-up of achalasic patients treated with botulinum toxin. Dis Esophagus. 2000;13(2):96–101. discussion 102-103. doi: 10.1046/j.1442-2050.2000.00094.x
  • Fishman VM, Parkman HP, Schiano TD, et al. Symptomatic improvement in achalasia after botulinum toxin injection of the lower esophageal sphincter. Am J Gastroenterol. 1996;91:1724–1730.
  • Marjoux S, Brochard C, Roman S, et al. Botulinum toxin injection for hypercontractile or spastic esophageal motility disorders: may high-resolution manometry help to select cases? Dis Esophagus. 2015;28(8):735–741. doi: 10.1111/dote.12282
  • Neubrand M, Scheurlen C, Schepke M, et al. Long-term results and prognostic factors in the treatment of achalasia with botulinum toxin. Endoscopy. 2002;34(7):519–523. doi: 10.1055/s-2002-33225
  • Pasricha PJ, Rai R, Ravich WJ, et al. Botulinum toxin for achalasia: long-term outcome and predictors of response. Gastroenterology. 1996;110(5):1410–1415. doi: 10.1053/gast.1996.v110.pm8613045
  • Porter RF, Gyawali CP. Botulinum toxin injection in dysphagia syndromes with preserved esophageal peristalsis and incomplete lower esophageal sphincter relaxation. Neurogastroenterol Motil. 2011;23:139-144, e127–138. doi:10.1111/j.1365-2982.2010.01604.x
  • Storr M, Born P, Frimberger E, et al. Treatment of achalasia: the short-term response to botulinum toxin injection seems to be independent of any kind of pretreatment. BMC Gastroenterol. 2002;2(1):19. doi: 10.1186/1471-230X-2-19
  • Jung HE, Lee JS, Lee TH, et al. Long-term outcomes of balloon dilation versus botulinum toxin injection in patients with primary achalasia. Korean J Intern Med. 2014;29(6):738–745. doi: 10.3904/kjim.2014.29.6.738
  • Leyden JE, Moss AC, MacMathuna P. Endoscopic pneumatic dilation versus botulinum toxin injection in the management of primary achalasia. Cochrane Database Syst Rev. 2014;CD005046. doi: 10.1002/14651858.CD005046.pub3
  • Allescher HD, Storr M, Seige M, et al. Treatment of achalasia: botulinum toxin injection vs. pneumatic balloon dilation. A prospective study with long-term follow-up. Endoscopy. 2001;33(12):1007–1017. doi: 10.1055/s-2001-18935
  • Kroupa R, Hep A, Dolina J, et al. Combined treatment of achalasia - botulinum toxin injection followed by pneumatic dilatation: long-term results. Dis Esophagus. 2010;23(2):100–105. doi: 10.1111/j.1442-2050.2009.01005.x
  • Mikaeli J, Bishehsari F, Montazeri G, et al. Injection of botulinum toxin before pneumatic dilatation in achalasia treatment: a randomized-controlled trial. Aliment Pharmacol Ther. 2006;24(6):983–989. doi: 10.1111/j.1365-2036.2006.03083.x
  • Zhu Q, Liu J, Yang C. Clinical study on combined therapy of botulinum toxin injection and small balloon dilation in patients with esophageal achalasia. Dig Surg. 2009;26(6):493–498. doi: 10.1159/000229784
  • Zaninotto G, Annese V, Costantini M, et al. Randomized controlled trial of botulinum toxin versus laparoscopic heller myotomy for esophageal achalasia. Ann Surg. 2004;239(3):364–370. doi: 10.1097/01.sla.0000114217.52941.c5
  • Vela MF, Richter JE, Wachsberger D, et al. Complexities of managing achalasia at a tertiary referral center: use of pneumatic dilatation, Heller myotomy, and botulinum toxin injection. Am J Gastroenterol. 2004;99(6):1029–1036. doi: 10.1111/j.1572-0241.2004.30199.x
  • Zaninotto G, Bennett C, Boeckxstaens G, et al. The 2018 ISDE achalasia guidelines. Dis Esophagus. 2018;31(9). doi: 10.1093/dote/doy071
  • Martinek J, Siroky M, Plottova Z, et al. Treatment of patients with achalasia with botulinum toxin: a multicenter prospective cohort study. Dis Esophagus. 2003;16(3):204–209. doi: 10.1046/j.1442-2050.2003.00329.x
  • Kolbasnik J, Waterfall WE, Fachnie B, et al. Long-term efficacy of botulinum toxin in classical achalasia: a prospective study. Am J Gastroenterol. 1999;94(12):3434–3439. doi: 10.1111/j.1572-0241.1999.01605.x
  • Martinek J, Spicak J. A modified method of botulinum toxin injection in patients with achalasia: a pilot trial. Endoscopy. 2003;35:841–844.
  • van Hoeij FB, Tack JF, Pandolfino JE, et al. Complications of botulinum toxin injections for treatment of esophageal motility disorders†. Dis Esophagus. 2017;30:1–5. doi: 10.1111/dote.12491
  • Kumar D, Zifan A, Mittal RK. Botox injection into the lower esophageal sphincter induces hiatal paralysis and gastroesophageal reflux. Am J Physiol Gastrointest Liver Physiol. 2020;318(1):G77–G83. doi: 10.1152/ajpgi.00238.2019
  • Chao CY, Raj A, Saad N, et al. Esophageal perforation, inflammatory mediastinitis and pseudoaneurysm of the thoracic aorta as potential complications of botulinum toxin injection for achalasia. Dig Endosc. 2015;27:618–621. doi:10.1111/den.12392
  • Mac Iver R, Liptay M, Johnson Y. A case of mediastinitis following botulinum toxin type a treatment for achalasia. Nat Clin Pract Gastroenterol Hepatol. 2007;4(10):579–582. doi: 10.1038/ncpgasthep0951
  • Annese V, Bassotti G, Coccia G, et al. A multicentre randomised study of intrasphincteric botulinum toxin in patients with oesophageal achalasia. GISMAD achalasia study group. Gut. 2000;46:597–600. doi: 10.1136/gut.46.5.597.
  • Zarate N, Mearin F, Baldovino F, et al. Achalasia treatment in the elderly: is botulinum toxin injection the best option? Eur J Gastroenterol Hepatol. 2002;14(3):285–290. doi: 10.1097/00042737-200203000-00013
  • Eisen GM, Baron TH, Dominitz JA, et al. Guideline on the management of anticoagulation and antiplatelet therapy for endoscopic procedures. Gastrointest Endosc. 2002;55(7):775–779. doi: 10.1016/S0016-5107(02)70402-1
  • Veitch AM, Radaelli F, Alikhan R, et al. Endoscopy in patients on antiplatelet or anticoagulant therapy: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guideline update. Endoscopy. 2021;53(9):947–969. doi: 10.1055/a-1547-2282
  • Boeckxstaens GE, Zaninotto G, Richter JE. Achalasia. Lancet. 2014;383:83–93.
  • van Hoeij FB, Prins LI, Smout A, et al. Efficacy and safety of pneumatic dilation in achalasia: a systematic review and meta-analysis. Neurogastroenterol Motil. 2019;31:e13548. doi:10.1111/nmo.13548
  • Weusten B, Barret M, Bredenoord AJ, et al. Endoscopic management of gastrointestinal motility disorders - part 1: European Society of gastrointestinal Endoscopy (ESGE) guideline. Endoscopy. 2020;52:498–515. doi: 10.1055/a-1160-5549.
  • Riley SA, Attwood SE. Guidelines on the use of oesophageal dilatation in clinical practice. Gut. 2004;53(Suppl 1):i1–6. doi:10.1136/gut.53.suppl_1.i1
  • Kuipers T, Ponds FA, Fockens P, et al. Peroral endoscopic myotomy versus pneumatic dilation in treatment-naive patients with achalasia: 5-year follow-up of a randomised controlled trial. Lancet Gastroenterol Hepatol. 2022;7(12):1103–1111. doi: 10.1016/S2468-1253(22)00300-4
  • Moonen A, Annese V, Belmans A et al. Long-term results of the European achalasia trial: a multicentre randomised controlled trial comparing pneumatic dilation versus laparoscopic Heller myotomy. Gut. 2016;65(5):732–739. doi: 10.1136/gutjnl-2015-310602
  • Khashab MA, Vela MF, Thosani N, et al. ASGE guideline on the management of achalasia. Gastrointest Endosc. 2020;91:213–227 e216. doi: 10.1016/j.gie.2019.04.231
  • Zerbib F, Thetiot V, Richy F, et al. Repeated pneumatic dilations as long-term maintenance therapy for esophageal achalasia. Am J Gastroenterol. 2006;101(4):692–697. doi: 10.1111/j.1572-0241.2006.00385.x
  • Alderliesten J, Conchillo JM, Leeuwenburgh I, et al. Predictors for outcome of failure of balloon dilatation in patients with achalasia. Gut. 2011;60(1):10–16. doi: 10.1136/gut.2010.211409
  • Dagli U, Kuran S, Savas N, et al. Factors predicting outcome of balloon dilatation in achalasia. Dig Dis Sci. 2009;54:1237–1242. doi: 10.1007/s10620-008-0493-6
  • Hulselmans M, Vanuytsel T, Degreef T, et al. Long-term outcome of pneumatic dilation in the treatment of achalasia. Clin Gastroenterol Hepatol. 2010;8(1):30–35. doi: 10.1016/j.cgh.2009.09.020
  • Kim GH, Jung KW, Jung HY, et al. Superior clinical outcomes of peroral endoscopic myotomy compared with balloon dilation in all achalasia subtypes. J Gastroenterol Hepatol. 2019;34(4):659–665. doi: 10.1111/jgh.14616
  • Metman EH, Lagasse JP, d’Alteroche L, et al. Risk factors for immediate complications after progressive pneumatic dilation for achalasia. Am J Gastroenterol. 1999;94(5):1179–1185. doi: 10.1111/j.1572-0241.1999.01062.x
  • Nair LA, Reynolds JC, Parkman HP, et al. Complications during pneumatic dilation for achalasia or diffuse esophageal spasm. Analysis of risk factors, early clinical characteristics, and outcome. Dig Dis Sci. 1993;38(10):1893–1904. doi: 10.1007/BF01296115
  • Ponce J, Garrigues V, Pertejo V, et al. Individual prediction of response to pneumatic dilation in patients with achalasia. Dig Dis Sci. 1996;41(11):2135–2141. doi: 10.1007/BF02071392
  • Lynch KL, Pandolfino JE, Howden CW, et al. Major complications of pneumatic dilation and Heller myotomy for achalasia: single-center experience and systematic review of the literature. Am J Gastroenterol. 2012;107(12):1817–1825. doi: 10.1038/ajg.2012.332
  • Markar SR, Mackenzie H, Askari A, et al. Population-based cohort study of surgical myotomy and pneumatic dilatation as primary interventions for oesophageal achalasia. Br J Surg. 2018;105(8):1028–1035. doi: 10.1002/bjs.10805
  • Mikaeli J, Bishehsari F, Montazeri G, et al. Pneumatic balloon dilatation in achalasia: a prospective comparison of safety and efficacy with different balloon diameters. Aliment Pharmacol Ther. 2004;20(4):431–436. doi: 10.1111/j.1365-2036.2004.02080.x
  • Reynoso JF, Tiwari MM, Tsang AW, et al. Does illness severity matter? A comparison of laparoscopic esophagomyotomy with fundoplication and esophageal dilation for achalasia. Surg Endosc. 2011;25(5):1466–1471. doi: 10.1007/s00464-010-1415-1
  • Shah SWH, Butt AK, Malik K, et al. Pneumatic balloon dilatation for achalasia cardia; early & late results, a single center study. Pak J Med Sci. 2017;33:1053–1058. doi:10.12669/pjms.335.13685
  • Vela MF, Richter JE, Khandwala F, et al. The long-term efficacy of pneumatic dilatation and Heller myotomy for the treatment of achalasia. Clin Gastroenterol Hepatol. 2006;4(5):580–587. doi: 10.1016/S1542-3565(05)00986-9
  • West RL, Hirsch DP, Bartelsman JF, et al. Long term results of pneumatic dilation in achalasia followed for more than 5 years. Am J Gastroenterol. 2002;97(6):1346–1351. doi: 10.1111/j.1572-0241.2002.05771.x
  • Campos GM, Vittinghoff E, Rabl C, et al. Endoscopic and surgical treatments for achalasia: a systematic review and meta-analysis. Ann Surg. 2009;249:45–57. doi: 10.1097/SLA.0b013e31818e43ab
  • Borotto E, Gaudric M, Danel B, et al. Risk factors of oesophageal perforation during pneumatic dilatation for achalasia. Gut. 1996;39(1):9–12. doi: 10.1136/gut.39.1.9
  • Vaezi MF, Pandolfino JE, Yadlapati RH, et al. ACG clinical guidelines: diagnosis and management of achalasia. Am J Gastroenterol. 2020;115(9):1393–1411. doi: 10.14309/ajg.0000000000000731
  • Katsinelos P, Kountouras J, Paroutoglou G, et al. Long-term results of pneumatic dilation for achalasia: a 15 years’ experience. World J Gastroenterol. 2005;11(36):5701–5705. doi: 10.3748/wjg.v11.i36.5701
  • Min YW, Lee JH, Min BH, et al. Association between gastroesophageal reflux disease after pneumatic balloon dilatation and clinical course in patients with achalasia. J Neurogastroenterol Motil. 2014;20(2):212–218. doi: 10.5056/jnm.2014.20.2.212
  • Tuset JA, Lujan M, Huguet JM, et al. Endoscopic pneumatic balloon dilation in primary achalasia: predictive factors, complications, and long-term follow-up. Dis Esophagus. 2009;22(1):74–79. doi: 10.1111/j.1442-2050.2008.00874.x
  • Bravi I, Nicita MT, Duca P, et al. A pneumatic dilation strategy in achalasia: prospective outcome and effects on oesophageal motor function in the long term. Aliment Pharmacol Ther. 2010;31(6):658–665. doi: 10.1111/j.1365-2036.2009.04217.x
  • Ponds FA, Fockens P, Lei A, et al. Effect of peroral endoscopic myotomy vs pneumatic dilation on symptom severity and treatment outcomes among treatment-naive patients with achalasia: a randomized clinical trial. JAMA. 2019;322(2):134–144. doi: 10.1001/jama.2019.8859
  • Rai RR, Shende A, Joshi A, et al. Rigiflex pneumatic dilation of achalasia without fluoroscopy: a novel office procedure. Gastrointest Endosc. 2005;62(3):427–431. doi: 10.1016/j.gie.2005.04.008
  • Boeckxstaens GE, Annese V, des Varannes SB, et al. Pneumatic dilation versus laparoscopic Heller’s myotomy for idiopathic achalasia. N Engl J Med. 2011;364:1807–1816. doi: 10.1056/NEJMoa1010502
  • Rohof WO, Salvador R, Annese V, et al. Outcomes of treatment for achalasia depend on manometric subtype. Gastroenterology. quiz e713-714. 2013;144:718–725. doi: 10.1053/j.gastro.2012.12.027
  • Farhoomand K, Connor JT, Richter JE, et al. Predictors of outcome of pneumatic dilation in achalasia. Clin Gastroenterol Hepatol. 2004;2:389–394. doi:10.1016/S1542-3565(04)00123-5
  • Tanaka Y, Iwakiri K, Kawami N, et al. Predictors of a better outcome of pneumatic dilatation in patients with primary achalasia. J Gastroenterol. 2010;45(2):153–158. doi: 10.1007/s00535-009-0145-4
  • Eckardt VF, Aignherr C, Bernhard G. Predictors of outcome in patients with achalasia treated by pneumatic dilation. Gastroenterology. 1992;103(6):1732–1738. doi: 10.1016/0016-5085(92)91428-7
  • Parkman HP, Reynolds JC, Ouyang A, et al. Pneumatic dilatation or esophagomyotomy treatment for idiopathic achalasia: clinical outcomes and cost analysis. Dig Dis Sci. 1993;38(1):75–85. doi: 10.1007/BF01296777
  • Mehta R, John A, Sadasivan S, et al. Factors determining successful outcome following pneumatic balloon dilation in achalasia cardia. Indian J Gastroenterol. 2005;24:243–245.
  • Ghoshal UC, Rangan M. A review of factors predicting outcome of pneumatic dilation in patients with achalasia cardia. J Neurogastroenterol Motil. 2011;17(1):9–13. doi: 10.5056/jnm.2011.17.1.9
  • Rohof WO, Hirsch DP, Kessing BF, et al. Efficacy of treatment for patients with achalasia depends on the distensibility of the esophagogastric junction. Gastroenterology. 2012;143(2):328–335. doi: 10.1053/j.gastro.2012.04.048
  • Smeets FG, Masclee AA, Keszthelyi D, et al. Esophagogastric junction distensibility in the management of achalasia patients: relation to treatment outcome. Neurogastroenterol Motil. 2015;27(10):1495–1503. doi: 10.1111/nmo.12651
  • Wu PI, Szczesniak MM, Craig PI, et al. Novel intra-procedural distensibility measurement accurately predicts immediate outcome of pneumatic dilatation for idiopathic achalasia. Am J Gastroenterol. 2018;113(2):205–212. doi: 10.1038/ajg.2017.411
  • Allaix ME, Patti MG. Heller myotomy for achalasia. From the open to the laparoscopic approach. World J Surg. 2015;39(7):1603–1607. doi: 10.1007/s00268-014-2914-3
  • Milone M, Manigrasso M, Vertaldi S, et al. Robotic versus laparoscopic approach to treat symptomatic achalasia: systematic review with meta-analysis. Dis Esophagus. 2019;32(10):1–8. doi: 10.1093/dote/doz062
  • Shaligram A, Unnirevi J, Simorov A, et al. How does the robot affect outcomes? A retrospective review of open, laparoscopic, and robotic Heller myotomy for achalasia. Surg Endosc. 2012;26(4):1047–1050. doi: 10.1007/s00464-011-1994-5
  • Douketis JD, Spyropoulos AC, Spencer FA, et al. Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of Thrombosis, 9th ed: American College of chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141:e326–e350. doi: 10.1378/chest.11-2298
  • Li J, Montorfano L, Chang O, et al. Laparoscopic Heller Myotomy. In: Rosenthal R, Rosales A, Lo Menzo E Dip F, editors Mental conditioning to perform common operations in General surgery training: a systematic approach to expediting skill acquisition and maintaining dexterity in performance. Cham: Springer International Publishing; 2020. p. 159–164.
  • Zaninotto G, Costantini M, Rizzetto C, et al. Four hundred laparoscopic myotomies for esophageal achalasia: a single centre experience. Ann Surg. 2008;248(6):986–993. doi: 10.1097/SLA.0b013e3181907bdd
  • Ross SW, Oommen B, Wormer BA, et al. National outcomes of laparoscopic Heller myotomy: operative complications and risk factors for adverse events. Surg Endosc. 2015;29(11):3097–3105. doi: 10.1007/s00464-014-4054-0
  • Wang YR, Dempsey DT, Friedenberg FK, et al. Trends of Heller myotomy hospitalizations for achalasia in the United States, 1993-2005: effect of surgery volume on perioperative outcomes. Am J Gastroenterol. 2008;103(10):2454–2464. doi: 10.1111/j.1572-0241.2008.02049.x
  • Zhang LP, Chang R, Matthews BD, et al. Incidence, mechanisms, and outcomes of esophageal and gastric perforation during laparoscopic foregut surgery: a retrospective review of 1,223 foregut cases. Surg Endosc. 2014;28(1):85–90. doi: 10.1007/s00464-013-3167-1
  • Kilic A, Schuchert MJ, Pennathur A, et al. Long-term outcomes of laparoscopic Heller myotomy for achalasia. Surgery discussion 831-823. 2009;146:826–831. doi: 10.1016/j.surg.2009.06.049
  • Schuchert MJ, Luketich JD, Landreneau RJ, et al. Minimally-invasive esophagomyotomy in 200 consecutive patients: factors influencing postoperative outcomes. Ann Thorac Surg. 2008;85(5):1729–1734. doi: 10.1016/j.athoracsur.2007.11.017
  • Rosemurgy AS, Morton CA, Rosas M, et al. A single institution’s experience with more than 500 laparoscopic Heller myotomies for achalasia. J Am Coll Surg. 2010;210(5):637-645, 645–637. doi: 10.1016/j.jamcollsurg.2010.01.035
  • Krishnamohan P, Allen MS, Shen KR, et al. Long-term outcome after laparoscopic myotomy for achalasia. J Thorac Cardiovasc Surg Discussion 736-737. 2014;147:730–736. doi: 10.1016/j.jtcvs.2013.09.063
  • Chrystoja CC, Darling GE, Diamant NE, et al. Achalasia-specific quality of life after pneumatic dilation or laparoscopic Heller myotomy with partial fundoplication: a multicenter, randomized clinical trial. Am J Gastroenterol. 2016;111(11):1536–1545. doi: 10.1038/ajg.2016.402
  • Hamdy E, El Nakeeb A, El Hanfy E, et al. Comparative study between laparoscopic Heller myotomy versus pneumatic dilatation for treatment of early achalasia: a prospective randomized study. J Laparoendosc Adv Surg Tech A. 2015;25:460–464. doi: 10.1089/lap.2014.0682
  • Hungness ES, Teitelbaum EN, Santos BF, et al. Comparison of perioperative outcomes between peroral esophageal myotomy (POEM) and laparoscopic Heller myotomy. J Gastrointest Surg. 2013;17(2):228–235. doi: 10.1007/s11605-012-2030-3
  • Podboy AJ, Hwang JH, Rivas H, et al. Long-term outcomes of per-oral endoscopic myotomy compared to laparoscopic Heller myotomy for achalasia: a single-center experience. Surg Endosc. 2021;35(2):792–801. doi: 10.1007/s00464-020-07450-6
  • Khoraki J, Campos GM, Alwatari Y, et al. Perioperative outcomes of inpatient laparoscopic Heller myotomy and per-oral endoscopic myotomy in the United States. Surgery. 2022;171(5):1263–1272. doi: 10.1016/j.surg.2021.10.019
  • Yadlapati R, Hungness ES, Pandolfino JE. Complications of antireflux surgery. Am J Gastroenterol. 2018;113(8):1137–1147. doi: 10.1038/s41395-018-0115-7
  • Repici A, Fuccio L, Maselli R, et al. GERD after per-oral endoscopic myotomy as compared with Heller’s myotomy with fundoplication: a systematic review with meta-analysis. Gastrointest Endosc. 2018;87:934–943 e918. doi: 10.1016/j.gie.2017.10.022
  • Midya S, Ghosh D, Mahmalat MW, Fundoplication in laparoscopic Heller’s cardiomyotomy for achalasia. Cochrane Database Of Systematic Reviews. 12: CD013386, 2022. 2022; 10.1002/14651858.CD013386.pub2.
  • Kurian AA, Bhayani N, Sharata A, et al. Partial anterior vs partial posterior fundoplication following transabdominal esophagocardiomyotomy for achalasia of the esophagus: meta-regression of objective postoperative gastroesophageal reflux and dysphagia. JAMA Surg. 2013;148(1):85–90. doi: 10.1001/jamasurgery.2013.409
  • Snyder CW, Burton RC, Brown LE, et al. Multiple preoperative endoscopic interventions are associated with worse outcomes after laparoscopic Heller myotomy for achalasia. J Gastrointest Surg. 2009;13(12):2095–2103. doi: 10.1007/s11605-009-1049-6
  • Sweet MP, Nipomnick I, Gasper WJ, et al. The outcome of laparoscopic Heller myotomy for achalasia is not influenced by the degree of esophageal dilatation. J Gastrointest Surg. 2008;12(1):159–165. doi: 10.1007/s11605-007-0275-z
  • Salvador R, Savarino E, Pesenti E, et al. Effects of laparoscopic myotomy on the esophageal motility pattern of esophageal achalasia as measured by high-resolution manometry. Surg Endosc. 2017;31(9):3510–3518. doi: 10.1007/s00464-016-5377-9
  • Smith CD, Stival A, Howell DL, et al. Endoscopic therapy for achalasia before Heller myotomy results in worse outcomes than heller myotomy alone. Ann Surg. 2006;243:579–584. discussion 584-576. doi: 10.1097/01.sla.0000217524.75529.2d
  • de Santiago E R, Shimamura Y, Pioche M, et al. Safety and effectiveness of peroral endoscopic myotomy in patients on antiplatelet or anticoagulant therapy: an international multicenter case-control study. Gastrointest Endosc. 2021;93:839–849. doi: 10.1016/j.gie.2020.07.030
  • Loser B, Recio Ariza O, Saugel B, et al. Anesthesia for patients undergoing peroral endoscopic myotomy procedures: a review of the literature. Anesth Analg. 2020;130(5):1331–1340. doi: 10.1213/ANE.0000000000004420
  • Zhang LY, Bejjani M, Ghandour B, et al. Through-the-scope suture closure of peroral endoscopic myotomy mucosal incision sites. Endoscopy. 2023;55:186–191.
  • Nabi Z, Nageshwar Reddy D. Impact of modified techniques on outcomes of peroral endoscopic myotomy: a narrative review. Front Med. 2022;9:948299. doi:10.3389/fmed.2022.948299
  • Akintoye E, Kumar N, Obaitan I, et al. Peroral endoscopic myotomy: a meta-analysis. Endoscopy. 2016;48(12):1059–1068. doi: 10.1055/s-0042-114426
  • Vespa E, Pellegatta G, Chandrasekar VT, et al. Long-term outcomes of peroral endoscopic myotomy for achalasia: a systematic review and meta-analysis. Endoscopy. 2023;55(2):167–175. doi: 10.1055/a-1894-0147
  • Nabi Z, Mandavdhare H, Akbar W, et al. Long-term outcome of peroral endoscopic myotomy in esophageal motility disorders: a systematic review and meta-analysis. J Clin Gastroenterol. 2023;57(3):227–238. doi: 10.1097/MCG.0000000000001776.
  • Facciorusso A, Ramai D, Ichkhanian Y, et al. Peroral endoscopic myotomy for the treatment of esophageal diverticula: a systematic review and meta-analysis. J Clin Gastroenterol. 2022;56(10):853–862. doi: 10.1097/MCG.0000000000001622
  • Kamal F, Ismail MK, Khan MA, et al. Efficacy and safety of peroral endoscopic myotomy in the management of recurrent achalasia after failed Heller myotomy: a systematic review and meta-analysis. Ann Gastroenterol. 2021;34:155–163. doi: 10.20524/aog.2020.0563
  • Tan S, Zhong C, Ren Y, et al. Efficacy and safety of peroral endoscopic myotomy in achalasia patients with failed previous intervention: a systematic review and meta-analysis. Gut Liver. 2021;15(2):153–167. doi: 10.5009/gnl19234
  • Huang Z, Cui Y, Li Y, et al. Peroral endoscopic myotomy for patients with achalasia with previous Heller myotomy: a systematic review and meta-analysis. Gastrointest Endosc. 2021;93:47–56 e45. doi:10.1016/j.gie.2020.05.056
  • Mandavdhare HS, PK M, Shukla J, et al. Role of peroral endoscopic myotomy in advanced achalasia cardia with sigmoid and/or megaesophagus: a systematic review and Metanalysis. J Neurogastroenterol Motil. 2022;28:15–27. doi:10.5056/jnm21122
  • Wessels E, Schuitenmaker JM, Bastiaansen BAJ, et al. Efficacy and safety of peroral endoscopic myotomy for esophageal diverticula. Endosc Int Open 0. May 26;11(5):E546–E552. doi: 10.1055/a-2071-6744. PMID: 37251790; PMCID: PMC10219786.
  • Mohan BP, Ofosu A, Chandan S, et al. Anterior versus posterior approach in peroral endoscopic myotomy (POEM): a systematic review and meta-analysis. Endoscopy. 2020;52(4):251–258. doi: 10.1055/a-1090-0788
  • Kane ED, Budhraja V, Desilets DJ, et al. Myotomy length informed by high-resolution esophageal manometry (HREM) results in improved per-oral endoscopic myotomy (POEM) outcomes for type III achalasia. Surg Endosc. 2019;33(3):886–894. doi: 10.1007/s00464-018-6356-0
  • Ghazaleh S, Beran A, Khader Y, et al. Short versus standard peroral endoscopic myotomy for esophageal achalasia: a systematic review and meta-analysis. Ann Gastroenterol. 2021;34:634–642. doi: 10.20524/aog.2021.0644
  • Cai MY, Zhou PH, Yao LQ, et al. Thoracic CT after peroral endoscopic myotomy for the treatment of achalasia. Gastrointest Endosc. 2014;80(6):1046–1055. doi: 10.1016/j.gie.2014.05.004
  • Chartier M, Barat M, Dohan A, et al. Clinical impact of routine CT esophagogram after peroral endoscopic myotomy (POEM) for esophageal motility disorders. Endosc Int Open. 2021;9(9):E1355–E1360. doi: 10.1055/a-1512-9638
  • El Khoury R, Teitelbaum EN, Sternbach JM, et al. Evaluation of the need for routine esophagram after peroral endoscopic myotomy (POEM). Surg Endosc. 2016;30(7):2969–2974. doi: 10.1007/s00464-015-4585-z
  • Nast JF, Berliner C, Rosch T, et al. Endoscopy versus radiology in post-procedural monitoring after peroral endoscopic myotomy (POEM). Surg Endosc. 2018;32(9):3956–3963. doi: 10.1007/s00464-018-6137-9
  • Nabi Z, Reddy DN, Ramchandani M. Adverse events during and after per-oral endoscopic myotomy: prevention, diagnosis, and management. Gastrointest Endosc. 2018;87(1):4–17. doi: 10.1016/j.gie.2017.09.029
  • Weng CY, He CH, Zhuang MY, et al. Peroral endoscopic longer vs shorter esophageal myotomy for achalasia treatment: a systematic review and meta-analysis. World J Gastrointest Surg. 2022;14(3):247–259. doi: 10.4240/wjgs.v14.i3.247
  • Haito-Chavez Y, Inoue H, Beard KW, et al. Comprehensive analysis of adverse events associated with per oral endoscopic myotomy in 1826 patients: an international multicenter study. Am J Gastroenterol. 2017;112(8):1267–1276. doi: 10.1038/ajg.2017.139
  • Werner YB, von Renteln D, Noder T, et al. Early adverse events of per-oral endoscopic myotomy. Gastrointest Endosc. 2017;85:708–718 e702. doi: 10.1016/j.gie.2016.08.033
  • Inoue H, Sato H, Ikeda H, et al. Per-oral endoscopic myotomy: a series of 500 patients. J Am Coll Surg. 2015;221(2):256–264. doi: 10.1016/j.jamcollsurg.2015.03.057
  • Shiwaku H, Sato H, Shimamura Y, et al. Risk factors and long-term course of gastroesophageal reflux disease after peroral endoscopic myotomy: a large-scale multicenter cohort study in Japan. Endoscopy. 2022;54(9):839–847. doi: 10.1055/a-1753-9801
  • Familiari P, Greco S, Gigante G, et al. Gastroesophageal reflux disease after peroral endoscopic myotomy: analysis of clinical, procedural and functional factors, associated with gastroesophageal reflux disease and esophagitis. Dig Endosc. 2016;28:33–41. doi: 10.1111/den.12511
  • Kumbhari V, Familiari P, Bjerregaard NC, et al. Gastroesophageal reflux after peroral endoscopic myotomy: a multicenter case-control study. Endoscopy. 2017;49:634–642. doi: 10.1055/s-0043-105485
  • Chandan S, Facciorusso A, Khan SR, et al. Short versus standard esophageal myotomy in achalasia patients: a systematic review and meta-analysis of comparative studies. Endosc Int Open. 2021;9(8):E1246–E1254. doi: 10.1055/a-1490-8493
  • Duarte Chavez R, Marino D, Kahaleh M, et al. Endoscopic Treatment of Reflux: A Comprehensive Review. J Clin Gastroenterol. 2022;56(10):831–843. doi: 10.1097/MCG.0000000000001757
  • McCarty TR, Itidiare M, Njei B, et al. Efficacy of transoral incisionless fundoplication for refractory gastroesophageal reflux disease: a systematic review and meta-analysis. Endoscopy. 2018;50(7):708–725. doi: 10.1055/a-0576-6589
  • Kumta NA, Kedia P, Sethi A, et al. Transoral incisionless fundoplication for treatment of refractory GERD after peroral endoscopic myotomy. Gastrointest Endosc. 2015;81(1):224–225. doi: 10.1016/j.gie.2014.05.321
  • Tyberg A, Choi A, Gaidhane M, et al. Transoral incisional fundoplication for reflux after peroral endoscopic myotomy: a crucial addition to our arsenal. Endosc Int Open. 2018;6:E549–E552. doi:10.1055/a-0584-6802
  • Brewer Gutierrez OI, Chang KJ, Benias PC, et al. Is transoral incisionless fundoplication (TIF) an answer to post-peroral endoscopic myotomy gastroesophageal reflux? A multicenter retrospective study. Endoscopy. 2022;54(3):305–309. doi: 10.1055/a-1446-8953
  • Inoue H, Ueno A, Shimamura Y, et al. Peroral endoscopic myotomy and fundoplication: a novel NOTES procedure. Endoscopy. 2019;51(2):161–164. doi: 10.1055/a-0820-2731
  • Abe H, Tanaka S, Sato H, et al. Risk scoring system for the preprocedural prediction of the clinical failure of peroral endoscopic myotomy: a multicenter case-control study. Endoscopy. 2023;55:217–224. doi: 10.1055/a-1876-7554
  • Kim WH, Cho JY, Ko WJ, et al. Comparison of the outcomes of peroral endoscopic myotomy for achalasia according to Manometric Subtype. Gut Liver. 2017;11(5):642–647. doi: 10.5009/gnl16545
  • Zhang XC, Li QL, Xu MD, et al. Major perioperative adverse events of peroral endoscopic myotomy: a systematic 5-year analysis. Endoscopy. 2016;48(11):967–978. doi: 10.1055/s-0042-110397
  • Puli SR, Wagh MS, Forcione D, et al. Learning curve for esophageal peroral endoscopic myotomy: a systematic review and meta-analysis. Endoscopy. 2023;55(4):355–360. doi: 10.1055/a-1935-1093
  • Mota RCL, de Moura EGH, de Moura DTH, et al. Risk factors for gastroesophageal reflux after POEM for achalasia: a systematic review and meta-analysis. Surg Endosc. 2021;35(1):383–397. doi: 10.1007/s00464-020-07412-y
  • Werner YB, Hakanson B, Martinek J, et al. Endoscopic or surgical myotomy in patients with idiopathic achalasia. N Engl J Med. 2019;381(23):2219–2229. doi: 10.1056/NEJMoa1905380
  • Schlottmann F, Luckett DJ, Fine J, et al. Laparoscopic Heller myotomy versus peroral endoscopic myotomy (POEM) for achalasia: a systematic review and meta-analysis. Ann Surg. 2018;267(3):451–460. doi: 10.1097/SLA.0000000000002311
  • Ponds FA, Oors JM, Smout A, et al. Reflux symptoms and oesophageal acidification in treated achalasia patients are often not reflux related. Gut. 2021;70(1):30–39. doi: 10.1136/gutjnl-2020-320772
  • Saleh CMG, Familiari P, Bastiaansen BAJ, et al. The efficacy of peroral endoscopic myotomy vs pneumatic dilation as treatment for patients with achalasia suffering from persistent or recurrent symptoms after laparoscopic Heller myotomy: a randomized clinical trial. Gastroenterology. 2023;164:1108–1118 e1103. doi: 10.1053/j.gastro.2023.02.048

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.